SSII on Nasdaq
SS Innovations International, Inc.
American surgical and medical instruments and apparatus company. Summary from the record
$2.65 down 0.06 (2.04%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 19, 2026.
Overview
Compare with KORU Medical Systems, Inc., Brainsway Ltd. or SANUWAVE Health, Inc., or pick any stock.
- TickerSSII on Nasdaq2
- IndustrySurgical & Medical Instruments & Apparatus2
- HeadquartersFort Lauderdale, United States2
- Incorporated inFL4
- Business address405, 3Rd Floor, Ilabs Info Tech Centre, Udyog Vihar, Phase Iii, Gurugram, 1220164
- Filer categoryNon-accelerated filer, Smaller reporting company4
- Legal formCorporation2
- LEI549300R1NOCJPRJEMP712
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O COHEN, BARRY F, 33316 Fort Lauderdale, United States2
- Registered withFlorida Division of Corporations, P150000117222
See how the biggest companies compare on our leaderboards
Floor, iLabs Info Technology Centre, Udyog Vihar, Phase III, Gurugram, Haryana 122016, India. Our telephone number is +91 73375 53469.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
System Sales brought in 90% of the revenue SS Innovations International, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| System Sales | $19.5M | $38.4M |
| Instruments Sale | $942.5K | $3.2M |
| Warranty Sale | $177.5K | $877.0K |
| Lease Income | $71.7K | $70.9K |
Regions
India brought in 87% of the revenue SS Innovations International, Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| India | $19.1M | $36.8M |
| PH | $2.2M | |
| ID | $595.9K | $1.0M |
| South America | $468.2K | $1.0M |
| IQ | $766.3K | |
| CY | $522.3K | |
| OM | $85.4K | |
| AE | $31.3K | |
| NP | $501.7K | $18.7K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue50¢$22.9M
- Research and development8¢$3.7M
- Selling, general and admin33¢$14.8M
- Income tax9¢$4.0M
Out of $42.5M in revenue.6 The company lost money this year.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.4M7 | $5.9M7 | $20.6M6 | $42.5M6 | |||
| Cost of revenue | $1.4M7 | $5.1M8 | $12.2M6 | $22.9M6 | |||
| Gross profit | $60.6K7 | $725.5K8 | $8.5M6 | $19.5M6 | |||
| Research and development | $60.9K9 | $3.0K10 | $1.0K11 | $987.4K7 | $1.1M8 | $2.5M6 | $3.7M6 |
| Selling, general and admin | $1.9M7 | $10.1M8 | $10.2M6 | $14.8M6 | |||
| Operating expenses | $1.4M11 | $3.0M7 | $21.0M8 | $27.4M6 | $27.7M6 | ||
| Operating income | -$3.0M7 | -$20.3M8 | -$19.0M6 | -$8.2M6 | |||
| Interest | $19.7K9 | $1.1K10 | $162.0K14 | $523.4K14 | |||
| Income before tax | -$1.5M11 | -$3.2M7 | -$20.9M8 | -$19.2M6 | -$8.2M6 | ||
| Income tax | $4.0M6 | ||||||
| Net income | -$3.4M9 | -$1.1M10 | -$1.5M11 | -$3.2M7 | -$20.9M8 | -$19.2M6 | -$12.1M6 |
| Earnings per share | -$0.169 | -$0.0510 | -$0.0511 | -$0.037 | -$0.148 | -$0.116 | -$0.066 |
| Earnings per share (diluted) | -$0.169 | -$0.0510 | -$0.0511 | -$0.037 | -$0.148 | -$0.116 | -$0.066 |
| Shares (weighted, basic) | 28.5M shares11 | 128.2M shares7 | 144.9M shares8 | 170.8M shares6 | 190.0M shares6 | ||
| Shares (weighted, diluted) | 28.5M shares11 | 128.2M shares7 | 152.1M shares8 | 181.2M shares6 | 198.7M shares6 |
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash | $28.5K15 | $160.7K10 | $405.8K10 | $217.2K7 | $2.0M8 | $466.5K6 | $3.2M6 |
| Receivables | $156.9K7 | $1.9M8 | $4.5M6 | $12.4M6 | |||
| Inventory | $904.1K7 | $7.0M8 | $10.2M6 | $17.1M6 | |||
| Current assets | $34.8K9 | $163.0K10 | $408.1K11 | $4.1M7 | $21.4M8 | $27.4M6 | $48.8M6 |
| Property, plant and equipment | $20.5K11 | $417.0K7 | $706.4K8 | $5.4M6 | $9.1M6 | ||
| Total assets | $132.5K9 | $317.9K10 | $428.6K11 | $7.0M7 | $31.5M8 | $42.4M6 | $74.2M6 |
| Accounts payable | $124.6K11 | $165.5K7 | $901.6K8 | $2.3M6 | $5.1M6 | ||
| Short-term debt | $120.9K7 | $510.2K8 | |||||
| Current liabilities | $1.2M9 | $1.2M10 | $287.3K11 | $7.8M7 | $8.5M8 | $21.3M6 | $26.2M6 |
| Long-term debt | $469.0K7 | $510.2K7 | |||||
| Long-term liabilities | $1.9M7 | $3.3M8 | $7.6M8 | ||||
| Total liabilities | $9.7M7 | $11.8M8 | $28.9M6 | $36.0M6 | |||
| Retained earnings | -$8.5M11 | -$3.6M7 | -$24.5M8 | -$43.7M6 | -$55.8M6 | ||
| Shareholders’ equity | -$1.1M9 | -$869.0K11 | $585.6K7 | -$2.7M8 | $19.7M6 | $13.5M6 | $38.2M6 |
| Shares outstanding | 21.9M shares9 | 25.7M shares10 | 37.8M shares11 | 128.2M shares7 | 170.7M shares8 | 171.6M shares6 | 194.2M shares6 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$424.1K9 | -$90.5K10 | -$363.0K11 | -$6.0M7 | -$15.4M8 | -$9.5M6 | -$18.5M6 |
| Depreciation and amortization | $18.8K11 | $96.6K7 | $152.7K8 | $436.0K6 | $1.1M6 | ||
| Stock-based compensation | $767.2K11 | $865.5K14 | $9.7M8 | $14.3M6 | $8.1M6 | ||
| Capital spending | $220.3K14 | $453.3K8 | $661.5K6 | $3.7M6 | |||
| Free cash flow | -$6.2M | -$15.8M | -$10.2M | -$22.2M | |||
| Cash from investing | $38.1K11 | $240.8K7 | -$453.3K8 | -$661.5K6 | -$3.7M6 | ||
| Share buybacks | $26.0K10 | ||||||
| Cash from financing | $569.9K11 | $5.9M7 | $22.8M8 | $9.4M6 | $26.2M6 |
Compare SS Innovations International, Inc. with another company
Leadership
Who has led SS Innovations International, Inc., and when. Pick a name to see everywhere that person has worked.
President
Chief financial officer
Chief operating officer
- Chief executive officerPascual Srivastava Vishwajyoti Feb 20, 2026 to now16
- Chief executive officerSudhir Srivastava Nov 9, 2023 to Feb 20, 202617
- ChairSudhir Srivastava Nov 9, 2023 to now17
- PresidentPascual Srivastava Vishwajyoti Nov 9, 2023 to Nov 29, 202318
- Chief financial officerMilan Rao Jan 30, 2026 to Aug 4, 202619
- Chief financial officerSarah Romano Aug 4, 2026 to now20
- Chief financial officerArvind Palaniappan Palaniappan May 19, 2025 to Oct 3, 202521
- Chief financial officerNaveen Kumar Amar Oct 3, 2025 to Jan 30, 202622
- Chief financial officerKumar Sethi Anup Nov 9, 2023 to May 19, 202523
- Chief operating officerMilan Rao Jan 30, 2026 to now19
Board members and other officers (5)
- Board memberFrederic H. Moll Aug 22, 2024 to now24
- Board memberTimothy P. Adams Aug 23, 2024 to now25
- Board memberAnnadurai Mylswamy Nov 9, 2023 to Nov 9, 202326
- Board memberSampige Prasannakumar Somashekar Nov 9, 2023 to now27
- Board memberPascual Srivastava Vishwajyoti Nov 29, 2023 to now28
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Chief Operating Officer - Americas and DirectorBarry F. Cohen named Feb 27, 2024 to Mar 19, 202629
- Chief Executive Officer - Asia Pacific and DirectorVishwajyoti P. Srivastava named Feb 27, 2024 to Mar 19, 202629
- Executive OfficerAnup Kumar Sethi named Feb 27, 202430
- DirectorMylswamy F. Annadurai named Feb 27, 2024 to Mar 19, 202629
- DirectorS.P. F. Somashekhar named Feb 27, 2024 to Mar 19, 202629
Former names
- AVRA Medical Robotics, Inc.Jun 3, 2016 to Apr 14, 20234
Timeline
Filings
263 filings to the SEC since October 2021: 10 annual reports, 25 quarterly reports, 104 major events, 93 insider forms, 10 large holders, 2 private raises, 19 other. The latest 20:
- Oct 13, 20268-K CURRENT REPORT EDGAR
- Oct 13, 20268-K CURRENT REPORT EDGAR
- Oct 9, 20264 EDGAR
- Oct 9, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
- Oct 5, 20268-K CURRENT REPORT EDGAR
- Sep 10, 20268-K CURRENT REPORT EDGAR
- Sep 9, 20264 EDGAR
- Aug 26, 20268-K CURRENT REPORT EDGAR
- Aug 14, 20264 EDGAR
- Aug 13, 20268-K CURRENT REPORT EDGAR
- Aug 13, 202610-Q QUARTERLY REPORT EDGAR
- Aug 4, 20263 EDGAR
- Jul 17, 20268-K CURRENT REPORT EDGAR
- Jul 14, 20268-K CURRENT REPORT EDGAR
- Jul 7, 20268-K CURRENT REPORT EDGAR
- Jun 30, 20268-K CURRENT REPORT EDGAR
- Jun 18, 20268-K CURRENT REPORT EDGAR
- Jun 18, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
- Jun 15, 20268-K CURRENT REPORT EDGAR
- Jun 8, 2026S-8 REGISTRATION STATEMENT EDGAR
The 263 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
58 open-market trades by officers, directors and large owners since October 2021: 46 buys and 12 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Sudhir SrivastavaChairman and CEO | Sale | 33,333 | $3.00 | $100.0K | Form 4 |
| Mar 6, 2026 | MOLL FREDERIC HDirector | Buy | 501,253 | $3.99 | $2.0M | Form 4 |
| Mar 6, 2026 | Adams Timothy P.Director | Buy | 300,000 | $3.99 | $1.2M | Form 4 |
| Mar 6, 2026 | Sudhir SrivastavaChairman and CEO | Buy | 498,753 | $4.01 | $2.0M | Form 4 |
| Apr 22, 2025 | Cohen Barry FCOO - Americas | Buy | 326 | $8.97 | $2.9K | Form 4 |
| Apr 22, 2025 | Cohen Barry FCOO - Americas | Buy | 326 | $8.97 | $2.9K | Form 4 |
| Apr 17, 2025 | Cohen Barry FCOO - Americas | Buy | 100 | $8.75 | $875 | Form 4 |
| Apr 17, 2025 | Cohen Barry FCOO - Americas | Buy | 100 | $8.75 | $875 | Form 4 |
| Apr 16, 2025 | Cohen Barry FCOO - Americas | Buy | 107 | $9.50 | $1.0K | Form 4 |
| Apr 14, 2025 | Cohen Barry FCOO - Americas | Buy | 103 | $8.93 | $920 | Form 4 |
| Apr 10, 2025 | Cohen Barry FCOO - Americas | Buy | 200 | $8.93 | $1.8K | Form 4 |
| Apr 9, 2025 | Cohen Barry FCOO - Americas | Buy | 300 | $8.47 | $2.5K | Form 4 |
| Apr 8, 2025 | Cohen Barry FCOO - Americas | Buy | 500 | $9.16 | $4.6K | Form 4 |
| Apr 2, 2025 | Cohen Barry FCOO - Americas | Buy | 420 | $9.20 | $3.9K | Form 4 |
| Apr 1, 2025 | Cohen Barry FCOO - Americas | Buy | 2,570 | $9.72 | $25.0K | Form 4 |
| Mar 31, 2025 | Cohen Barry FCOO - Americas | Buy | 100 | $10.00 | $1.0K | Form 4 |
| Feb 20, 2025 | MOLL FREDERIC HDirector | Buy | 3,645,224 | $1.37 | $5.0M | Form 4 |
| Feb 20, 2025 | SRIVASTAVA SUDHIRChairman and CEO | Sale | 3,645,224 | $1.37 | $5.0M | Form 4 |
| Feb 14, 2025 | Adams Timothy P.Director | Buy | 1,250,000 | $1.37 | $1.7M | Form 4 |
| Feb 14, 2025 | SRIVASTAVA SUDHIRChairman and CEO | Sale | 1,250,000 | $1.37 | $1.7M | Form 4 |
All 58 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Sudhir SrivastavaSCHEDULE 13G/A, 4 filings Feb 9, 2024 to May 4, 202631
- Frederic H. MollSCHEDULE 13G/A, 3 filings Feb 14, 2024 to May 15, 202532
- Barry F. CohenSCHEDULE 13G, 1 filing Feb 13, 202533
- Ranjan R. PaiSCHEDULE 13G/A, 2 filings Dec 2, 2024 to Feb 12, 202534
Money raised
Private offerings the company reported to the SEC on Form D.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Hood River Capital Management LLC | 833,333 | $3.5M | 0.0% | No change |
| Inspire Investing, LLC | 186,297 | $773.1K | 0.0% | +81,673 |
| Eversept Partners, LP | 110,157 | $457.2K | 0.0% | No change |
| JNBA Financial Advisors | 102,291 | $424.5K | 0.0% | −14,646 |
| UBS Group AG | 51,208 | $212.5K | 0.0% | −104,333 |
| AlphaCentric Advisors LLC | 50,000 | $207.5K | 0.2% | No change |
| Geode Capital Management, LLC | 41,771 | $173.3K | 0.0% | +5,495 |
| Forum Financial Management, LP | 38,469 | $159.6K | 0.0% | No change |
| AlTi Global, Inc. | 20,555 | $85.3K | 0.0% | No change |
| Mariner, LLC | 19,211 | $79.7K | 0.0% | +554 |
| IFC & Insurance Marketing, Inc. | 18,655 | $77.4K | 0.1% | +1,925 |
| Y-Intercept (Hong Kong) Ltd | 17,934 | $74.4K | 0.0% | New |
| State Street Corp | 14,522 | $60.3K | 0.0% | −1,064 |
| PNC Financial Services Group, Inc. | 13,627 | $56.6K | 0.0% | No change |
| Morgan Stanley | 3,000 | $12.4K | 0.0% | No change |
| Steward Partners Investment Advisory, LLC | 1,100 | $4.6K | 0.0% | No change |
| NFSG Corp | 916 | $3.8K | 0.0% | −400 |
| Jones Financial Companies Lllp | 376 | $1.3K | 0.0% | No change |
| Basecamp Wealth Advisors LLC | 300 | $1.2K | 0.0% | No change |
| Handelsbanken Fonder AB | 120,000 | $498 | 0.0% | No change |
| Osaic Holdings, Inc. | 10 | $41 | 0.0% | No change |
| Royal Bank Of Canada | 85 | $0 | 0.0% | −165 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3Yahoo FinanceSSII quote
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19SEC EDGARMilan Rao, Chief financial officer
- 20
- 21
- 22
- 23
- 24SEC EDGARFrederic H. Moll, Board member
- 25SEC EDGARTimothy P. Adams, Board member
- 26SEC EDGARAnnadurai Mylswamy, Board member
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34